Primary |
Diabetes Mellitus |
49.3% |
Type 2 Diabetes Mellitus |
43.6% |
Blood Glucose |
2.7% |
Blood Glucose Increased |
0.9% |
Hyperglycaemia |
0.9% |
Arthritis |
0.4% |
Blood Cholesterol |
0.4% |
Gastrooesophageal Reflux Disease |
0.4% |
Glycosylated Haemoglobin Increased |
0.4% |
Hypertension |
0.4% |
Product Used For Unknown Indication |
0.4% |
|
Blood Glucose Increased |
10.8% |
Diarrhoea |
10.8% |
Drug Ineffective |
10.2% |
Pancreatitis |
10.2% |
Inappropriate Schedule Of Drug Administration |
7.8% |
Nausea |
6.0% |
Product Quality Issue |
5.4% |
Rash |
4.8% |
Hypoglycaemia |
4.2% |
Blood Glucose Abnormal |
3.6% |
Gastrointestinal Disorder |
3.6% |
Medication Residue Present |
3.6% |
Adverse Event |
3.0% |
Wrong Technique In Drug Usage Process |
3.0% |
Dizziness |
2.4% |
Medication Residue |
2.4% |
Vomiting |
2.4% |
Angioedema |
1.8% |
Constipation |
1.8% |
Flatulence |
1.8% |
|
Secondary |
Diabetes Mellitus |
60.0% |
Type 2 Diabetes Mellitus |
36.4% |
Blood Glucose Increased |
3.6% |
|
Drug Ineffective |
19.4% |
Blood Glucose Increased |
16.7% |
Varices Oesophageal |
8.3% |
Blood Glucose Abnormal |
5.6% |
Myalgia |
5.6% |
Overdose |
5.6% |
Polyuria |
5.6% |
Abdominal Discomfort |
2.8% |
Diarrhoea |
2.8% |
Fatigue |
2.8% |
Headache |
2.8% |
Impaired Driving Ability |
2.8% |
Increased Appetite |
2.8% |
Lactic Acidosis |
2.8% |
Muscle Spasms |
2.8% |
Nausea |
2.8% |
No Adverse Event |
2.8% |
Product Packaging Issue |
2.8% |
Underdose |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
28.6% |
Diabetes Mellitus |
19.0% |
Hypertension |
14.3% |
Atrial Fibrillation |
9.5% |
Blood Cholesterol Abnormal |
4.8% |
Diabetic Neuropathy |
4.8% |
Erectile Dysfunction |
4.8% |
High Density Lipoprotein Decreased |
4.8% |
Nervous System Disorder |
4.8% |
Neuralgia |
4.8% |
|
Somnolence |
33.3% |
Blood Glucose Increased |
16.7% |
Drug Ineffective |
16.7% |
Rash |
16.7% |
Throat Tightness |
16.7% |
|